ERS statement on the multidisciplinary respiratory management of ataxia telangiectasia

Jayesh M Bhatt, Andrew Bush, Marjo van Gerven, Andreea Nissenkorn, Michael Renke, Lian Yarlett, Malcolm Taylor, Thomy Tonia, Adilia Warris, Stefan Zielen, Shairbanu Zinna, Peter J F M Merkus

Research output: Contribution to journalArticlepeer-review

31 Citations (Scopus)


Ataxia telangiectasia (A-T) is a rare, progressive, multisystem disease that has a large number of complex and diverse manifestations which vary with age. Patients with A-T die prematurely with the leading causes of death being respiratory diseases and cancer. Respiratory manifestations include immune dysfunction leading to recurrent upper and lower respiratory infections; aspiration resulting from dysfunctional swallowing due to neurodegenerative deficits; inefficient cough; and interstitial lung disease/pulmonary fibrosis. Malnutrition is a significant comorbidity. The increased radiosensitivity and increased risk of cancer should be borne in mind when requesting radiological investigations. Aggressive proactive monitoring and treatment of these various aspects of lung disease under multidisciplinary expertise in the experience of national multidisciplinary clinics internationally forms the basis of this statement on the management of lung disease in A-T. Neurological management is outwith the scope of this document.

Original languageEnglish
Pages (from-to)565-81
Number of pages17
JournalEuropean Respiratory Review
Issue number138
Publication statusPublished - 1 Dec 2015


Dive into the research topics of 'ERS statement on the multidisciplinary respiratory management of ataxia telangiectasia'. Together they form a unique fingerprint.

Cite this